Activation of protein kinase Cδ in human myeloid leukemia cells treated with 1-β-D-arabinofuranosylcytosine

Blood

Volumn 87, Issue 5, 1996, Pages 1990-1996

  Emoto, Yutaka ^a   Kisaki, Hiroshi ^a   Manome, Yoshinobu ^a   Kharbanda, Surender ^a   Kufe, Donald ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 (5 ISOQUINOLINESULFONYL) 2 METHYLPIPERAZINE; CAMPTOTHECIN; CYTARABINE; HERBIMYCIN A; MITOMYCIN C; MYELIN BASIC PROTEIN; N (2 METHYLAMINOETHYL) 5 ISOQUINOLINESULFONAMIDE; PROTEIN KINASE C; STAUROSPORINE;

ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; ENZYME ACTIVATION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; LEUKEMIA CELL; MYELOID LEUKEMIA; PRIORITY JOURNAL; PROTEIN DEGRADATION;

EID: 0030023982     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v87.5.1990.1990     Document Type: Article

References (48)

1. Frei E, Bickers JN, Hewitt JS, Lane M, Leary WV, Talley RW: Dose schedule and antitumor studies of arabinosyl cytosine. Cancer Res 29.1325, 1969
2. Major PP, Egan EM, Beardsley G, Minden M. Kufe DW: Lethality of human myeloblasts correlates with the incorporation of ara-C into DNA. Proc Natl Acad Sci USA 78:3235, 1981
3. Major PP, Egan EM, Herrick D, Kufe DW: The effect of ara-C incorporation on DNA synthesis in cells. Biochem Pharmacol 31:2937, 1982
4. Kufe D, Munroe D, Herrick D, Spriggs D: Effects of ara-C incorporation on eukaryotic DNA template function. Mol Pharmacol 26:128, 1984
5. Townsend A, Cheng Y-C: Sequence specific effects of ara-5-aza-CTP and ara-CTP on DNA synthesis by purified human DNA polymerases in vitro: Visualization of chain elongation on a defined template. Mol Pharmacol 32:330, 1987
6. Ohno Y, Spriggs D, Matsukage A, Ohno T, Kufe D: Effects of 1-β-D-arabinofuranosylcytosine incorporation on elongation of specific DNA sequences by DNA polymerase β. Cancer Res 48:1494, 1988
7. Cozzarelli N: The mechanism of action of inhibitors of DNA synthesis. Annu Rev Biochem 46:641, 1977
8. Fram RJ, Kufe D: DNA strand breaks caused by inhibitors of DNA synthesis: 1-β-D-Arabinofuranosylcytosine and aphidicolin. Cancer Res 42:4050, 1982
9. Gunji H, Kharbanda S, Kufe D: Induction of internucleosomal DNA fragmentation in human myeloid leukemia cells by 1-β-arabinofuranosylcytosine. Cancer Res 51:741, 1991
10. Kharbanda S, Sherman ML, Kufe D: Transcriptional regulation of c-jun gene expression by arabinofuranosylcytosine in human myeloid leukemia cells. J Clin Invest 86:1517, 1990
11. Brach M, Hermann F, Kufe DW: Activation of the AP-1 transcription factor by arabinofuranosylcytosine in myeloid leukemia cells. Blood 79:728, 1992
12. Brach M, Kharbanda S, Herrmann F, Kufe D: Activation of the transcription factor κB in human KG-1 myeloid leukemia cells treated with 1-β-D-arabinofuranosylcytosine. Mol Pharmacol 41:60, 1992
13. Sherman M, Stone R, Datta R, Bernstein S, Kufe D: Transcriptional and post-transcriptional regulation of c-jun expression during monocytic differentiation of human myeloid leukemic cells. J Biol Chem 265:3320, 1990
14. Ghosh S, Baltimore D: Activation in vitro of NF-κB by phosphorylation of its inhibitor IκB. Nature 344:678, 1990
15. Kharbanda S, Datta R, Kufe D: Regulation of c-jun gene expression in HL-60 leukemia cells by 1-β-D-arabinofuranosylcytosine. Potential involvement of a protein kinase C dependent mechanism. Biochemistry 30:7947, 1991
16. Kharbanda S, Emoto Y, Kisaki H, Saleem A, Kufe D: 1-β-D-Arabinofuranosylcytosine activates serine/threonine protein kinases and c-jun gene expression in phorbol ester-resistant myeloid leukemia cells. Mol Pharmacol 46:67, 1994
17. Knopf JL, Lee MH, Sultzman LA, Kriz RW, Looinis CR, Hewick RM, Bell RM: Cloning and expression of multiple protein kinase c cDNAs. Cell 46:491, 1986
18. Kameshita I, Fujisawa H: A sensitive method for detection of calmodulin-dependent protein kinase II activity in sodium dodecyl sulfate-polyacrylamide gel. Anal Biochem 183:139, 1989
19. Yasuda I, Kishimoto A, Tanaka S, Tominaga M, Sakurai A, Nishizuka Y: A synthetic peptide substrate for selective assay of protein kinase C. Biochem Biophys Res Commun 166:1220, 1990
20. Kishimoto A, Nishiyama K, Nakanishi H, Uratsuji Y, Nomura H, Takeyama Y, Nishizuka Y: Studies on the phosphorylation of myelin basic protein by protein kinase C and adenosine 3′:5′-monophosphate-dependent protein kinase. J Biol Chem 260:12492, 1985
21. Kishimoto A, Takai Y, Mori T, Kikkawa U, Nishizuka Y: Activation of calcium and phospholipid-dependent protein kinase by diacylglycerol, its possible relation to phosphatidylinositol turnover. J Biol Chem 255:2273, 1980
22. House C, Kemp BE: Protein kinase C contains a pseudosubstrate prototype in its regulatory domain. Science 238:1726, 1987a
23. Graff JM, Rajan RR, Randall RR, Nairn AC, Blackshear PJ: Protein kinase C substrate and inhibitor characteristics of peptides derived from the myristoylated alanine-rich C kinase substrate (MARCKS) protein phosphorylation site domain. J Biol Chem 266:14390, 1991
24. House C, Wettenhall REH, Kemp BE: The influence of basic residues on the substrate specificity of protein kinase C. J Biol Chem 262:772, 1987b
25. Tamaoki T, Nomoto H, Takahashi I, Kato Y, Motomoto M, Tomita F: Staurosporine, a potent inhibitor of phospholipid/Ca++ dependent protein kinase. Biochem Biophys Res Commun 135:397, 1986
26. Vegesna RV, Wu H-L, Mong S, Crooke ST: Staurosporine inhibits protein kinase C and prevents phorbol-ester-mediated leukotriene D4 receptor desensitization in RBL-1 cells. Mol Pharmacol 33:537, 1988
27. Hidaka H, Inagaki M, Kawamoto S, Sasaki Y: Isoquinoline-sulfonamides, novel and potent inhibitors of cyclic nucleotide x dependent protein kinase and protein kinase C. Biochemistry 23:5036, 1984
28. Uehara Y, Hori M, Takeuchi T, Umezawa H: Phenotypic change from transformed to normal induced by benzoquinonoid ansamycins accompanies inactivation of p60src in rat kidney cells infected with Rous sarcoma virus. Mol Cell Biol 6:2198, 1986
29. 2 homodimer. Cell 78:343, 1994
30. Enarl M, Hug H, Nagata S: Involvement of an ICE-like protease in Fas-mediated apoptosis. Nature 375:78, 1995
31. Shi L, Kraut RP, Aebersold R, Greenberg AM: A natural killer cell granule protein that induces DNA fragmentation and apoptosis. J Exp Med 175:553, 1992
32. Manome Y, Weichselbaum RR, Kufe DW, Fine HA: Effect of Bcl-2 on ionizing radiation and 1-β-D-arabinofuranosylcytosine-induced internucleosomal DNA fragmentation and cell survival in human myeloid leukemia cells. Oncol Res 5:139, 1993
33. L by cytotoxic drug exposure confers resistance to ionizing radiation - induced internucleosomal DNA fragmentation. Cell Growth Different 6.363, 1995
34. Kharbanda S, Rubin E, Gunji H, Hinz H, Giovanella B, Pantazis P, Kufe D: Camptothecin and its derivatives induce expression of the c-jun protooncogene in human myeloid leukemia cells. Cancer Res 51:6636, 1991
35. Tomasz M, Chawla AK, Lipman R: Mechanism of monofunctional and bifunctional alkylation of DNA by mitomycin C. Biochemistry 27:3182, 1988
36. Nishizuka Y: Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C. Science 258:607, 1992
37. Kishimoto A, Mikawa K, Hashimoto K, Yasuda I, Tanaka S-I, Tominaga M, Kuroda T, Nishizuka Y: Limited proteolysis of protein kinase C subspecies by calcium-dependent neutral protease (Calpain). J Biol Chem 264:4088, 1989
38. Watanabe T, Ono Y, Taniyama Y, Hazama K, Igarashi K, Ogita K, Kikkawa U, Nishizuka Y: Cell division arrest induced by phorbol ester in CHO cells overexpressing protein kinase C-δ subspecies. Proc Natl Acad Sci USA 89:10159, 1992
39. Mischak H, Bodenteich A, Kolch W, Goodnight J, Hofer F, Mushinski JF: Mouse protein kinase C-δ. the major isoform expressed in mouse hemopoietic cells: Sequence of the cDNA, expression patterns, and characterization of the protein. Biochemistry 30:7925, 1991
40. Li W, Mischak H, Yu J-C, Wang L-M, Mushinski JF, Heidaran MA, Pierce JH: Tyrosine phosphorylation of protein kinase C-δ in response to its activation. J Biol Chem 269:2349, 1994
41. Heusel JW, Wesselschmidt RL, Shresta S, Russell JH, Ley TJ. Cytotoxic lymphocytes require granzyme B for the rapid induction of DNA fragmentation and apoptosis in allogeneic target cells. Cell 76:977, 1994
42. Miura M, Zhu H, Rotello R, Hartwieg EA, Yuan J: Induction of apoptosis in fibroblasts by IL-1β-converting enzyme, a mammalian homolog of the C. elegans cell death gene ced-3. Cell 75:653, 1993
43. Nicholson DW, Ali A, Thornberry NA, Vaillancourt JP, Ding CK, Gallant M, Gareau Y, Griffin PR, Labelle M, Lazebnik YA, Munday NA, Raju SM, Smulson ME, Yamin T-T, Yu VL, Miller DK: Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature 376:37, 1995
44. Boise LH, Gonzaiz-Garcia M, Postema CE, Ding L, Lindsten T, Turka LA, Mao X, Nunez G, Thompson CB: Bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell 74:597, 1993
45. Rubin E, Kharbanda S, Gunji H, Weichselbaum R, Kufe D. Cisdiamminedichloroplatinum (II) induces c-jun expression in human leukemia cells: Potential involvement of a protein kinase C dependent signalling pathway Cancer Res 52:878, 1992
46. Rubin E, Kharbanda S, Gunji H, Kufe D: Activation of the c-jun protooncogene in human myeloid leukemia cells treated with etoposide. Mol Pharmacol 39:697, 1991
47. Collotta F, Polentarutti N, Sironi M, Mantovani A: Expression and involvement of c-fos and c-jun protooncogenes in programmed cell death induced by growth factor deprivation in lymphoid cell lines. J Biol Chem 267:18278, 1992
48. Boyle WJ, Smeal T, Defize LHK, Angel P, Woodgett JR, Karin M, Hunter T: Activation of protein kinase C decreases phosphorylation of c-jun at sites that negatively regulate its DNA-binding activity. Cell 64:573, 1991